Results 101 to 110 of about 1,092 (158)
Some of the next articles are maybe not open access.
Myeloma, Paraproteinemias, and the Skin
Medical Clinics of North America, 1986This review focuses on those systemic diseases or syndromes associated with monoclonal plasma cell disorders that may present with important cutaneous manifestations. Amyloidosis, POEMS syndrome, cutaneous plasmacytoma, xanthomas, benign hypergammaglobulinemic purpura of Waldenström, and scleromyxedema are emphasized.
Warren W Piëtte
exaly +3 more sources
Myeloma and other paraproteinemias
Postgraduate Medicine, 1977The paraproteinemias, a large heterogeneous group of diseases, are best characterized by the type of immunoglobulin moiety (paraprotein) produced. For the most common disorder, myeloma, response to treatment with alkylating agents has been objectively shown.
exaly +3 more sources
Rheumatoid factors in paraproteinemias
Research in Clinic and Laboratory, 1980H W Intorp
exaly +3 more sources
Paraproteinemia and neuropathy
Neurological Sciences, 2021Paraproteinemia is associated with different peripheral neuropathies. The major causes of neuropathy correlated with paraproteinemia are the deposition of immunoglobulin in the myelin, represented by anti-myelin-associated glycoprotein (MAG) neuropathy; deposition of immunoglobulin or its fragment in the interstitium, represented by immunoglobulin ...
Haruki Koike, Masahisa Katsuno
openaire +2 more sources
Plasmapheresis in paraproteinemia
Blut, 1985Indications, results, techniques, laboratory monitoring and complications of therapeutic plasmapheresis in patients with symptomatic paraproteinemia are reviewed. In paraproteinemia associated with severe complications plasma-pheresis has been used successfully as an emergency treatment, as a treatment that reduces temporarily the paraprotein level ...
H H, Euler, N, Schmitz, H, Löffler
openaire +2 more sources
La Ricerca in Clinica e in Laboratorio, 1985
According to the various case series, both myelomatous and non-myelomatous paraproteinemias are associated with a second malignant neoplasia in a frequency that ranges between 10 and 22%. This association, with a frequency higher than that statistically expected, is 2 to 4 times higher when compared to the association between two tumors of other origin.
L, Bonomo, F, Dammacco, A, Miglietta
openaire +2 more sources
According to the various case series, both myelomatous and non-myelomatous paraproteinemias are associated with a second malignant neoplasia in a frequency that ranges between 10 and 22%. This association, with a frequency higher than that statistically expected, is 2 to 4 times higher when compared to the association between two tumors of other origin.
L, Bonomo, F, Dammacco, A, Miglietta
openaire +2 more sources
Paraproteinemia and neuropathy
Current Opinion in Neurology, 1999Paraprotein-associated neuropathies are a diverse group of disorders. The pathogenesis of many of them is poorly understood. Treatments have usually consisted of plasma exchange, corticosteroids, intravenous immunoglobulin, and other immunosuppressive therapies. Response to treatment has varied from good to very poor. Most recent work in this field has
openaire +2 more sources
Necrobiotic xanthogranuloma with paraproteinemia
Journal of the American Academy of Dermatology, 1980Eight patients had multiple xanthomatous plaques and subcutaneous nodules that had a predilection for the periorbital area, flexures, and trunk and that tended to ulcerate. Skin biopsy specimens showed a combination of xanthogranulomatous nodules with necrobiosis.
S, Kossard, R K, Winkelmann
openaire +2 more sources